Previous 10 | Next 10 |
Achieve Life Sciences (NASDAQ: ACHV ): Q1 GAAP EPS of -$0.11 beats by $0.01 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program Canada NewsWire SEATTLE and VANCOUVER, British Columbia, May 14, 2020 SEATTLE and VANCOUVER, British Columbia , May 14, 2020 /CNW/ -- Achieve Life Sciences,...
SEATTLE and VANCOUVER, British Columbia , May 5, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addic...
Achieve Life Sciences (NASDAQ: ACHV ) has entered into definitive agreements for a private placement of 5,615,653 units at $0.33/unit, with each unit consisting of one common share and a warrant to purchase 0.75 shares of common stock, for gross proceeds of ~$1.9M. More news on: Ach...
Achieve Life Sciences Announces Private Placement of $1.9 Million Canada NewsWire SEATTLE and VANCOUVER, British Columbia, April 30, 2020 SEATTLE and VANCOUVER, British Columbia , April 30, 2020 /CNW/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharm...
- Will support Sera’s Transition from clinical to commercial stage company - - Sera positioned for growth with several outcome study read-outs taking place in 2020 - SALT LAKE CITY, April 02, 2020 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., The Pregnancy Company...
Achieve Life Sciences, Inc. (ACHV) Q4 2019 Results Earnings Conference Call March 13, 2020, 08:30 AM ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Executive Officer John Bencich - Chief Financial Officer Cindy Jacobs - Exec...
Achieve Life Sciences ( ACHV ) Q4 results : Revenues: $0; Net loss: ($3.2M) (+11.1%); loss/share: ($0.30) (+45.5%). More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, , Read more ...
Achieve Life Sciences (NASDAQ: ACHV ): Q4 GAAP EPS of -$0.30 beats by $0.02 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
SEATTLE and VANCOUVER, British Columbia , March 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, toda...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las Vegas, NV. Event website: https://planetmi...
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage pharmaceutic...
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it ...